These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16807128)

  • 1. Targeted inhibition of phosphoinositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure.
    Perrino C; Rockman HA; Chiariello M
    Vascul Pharmacol; 2006 Aug; 45(2):77-85. PubMed ID: 16807128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
    Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
    J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of beta-adrenergic receptor signaling and contractile function in heart failure by disruption of the betaARK1/phosphoinositide 3-kinase complex.
    Perrino C; Naga Prasad SV; Schroder JN; Hata JA; Milano C; Rockman HA
    Circulation; 2005 May; 111(20):2579-87. PubMed ID: 15897344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure].
    Schiattarella GG; Perrino C; Gargiulo G; Sorrentino S; Franzone A; Capretti G; Esposito G; Chiariello M
    G Ital Cardiol (Rome); 2010 Mar; 11(3):221-8. PubMed ID: 20550062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.
    Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ
    Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
    Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
    J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure.
    Perrino C; Schroder JN; Lima B; Villamizar N; Nienaber JJ; Milano CA; Naga Prasad SV
    Circulation; 2007 Nov; 116(22):2571-9. PubMed ID: 17998459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of receptor-localized PI3K preserves cardiac beta-adrenergic receptor function and ameliorates pressure overload heart failure.
    Nienaber JJ; Tachibana H; Naga Prasad SV; Esposito G; Wu D; Mao L; Rockman HA
    J Clin Invest; 2003 Oct; 112(7):1067-79. PubMed ID: 14523044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-mediated inhibition of the b-adrenergic receptor kinase: a new therapeutic strategy for heart failure.
    Tevaearai HT; Eckhart AD; Koch WJ
    Minerva Cardioangiol; 2001 Dec; 49(6):389-94. PubMed ID: 11733734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.
    Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ
    Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac regulation by phosphoinositide 3-kinases and PTEN.
    Oudit GY; Penninger JM
    Cardiovasc Res; 2009 May; 82(2):250-60. PubMed ID: 19147653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade.
    Iaccarino G; Tomhave ED; Lefkowitz RJ; Koch WJ
    Circulation; 1998 Oct; 98(17):1783-9. PubMed ID: 9788834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular restoration of beta-adrenergic receptor signaling improves contractile function of failing hearts.
    Tevaearai HT; Koch WJ
    Trends Cardiovasc Med; 2004 Aug; 14(6):252-6. PubMed ID: 15451518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Level of beta-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure.
    Tachibana H; Naga Prasad SV; Lefkowitz RJ; Koch WJ; Rockman HA
    Circulation; 2005 Feb; 111(5):591-7. PubMed ID: 15668342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic direct stimulation of adenylyl cyclase induces cardiac desensitization to catecholamine and beta-adrenergic receptor downregulation in rabbits.
    Takagi I; Nejima J; Kiuchi K; Takagi G; Takano T
    J Cardiovasc Pharmacol; 2006 Nov; 48(5):223-30. PubMed ID: 17110804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.
    White DC; Hata JA; Shah AS; Glower DD; Lefkowitz RJ; Koch WJ
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5428-33. PubMed ID: 10779554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices.
    Milting H; Scholz C; Arusoglu L; Freitag M; Cebulla R; Jaquet K; Körfer R; V Lewinski D; Kassner A; Brodde OE; Kögler H; El Banayosy A; Pieske B
    J Mol Cell Cardiol; 2006 Sep; 41(3):441-50. PubMed ID: 16765375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and phenotypic targeting of beta-adrenergic signaling in heart failure.
    Koch WJ
    Mol Cell Biochem; 2004 Aug; 263(1-2):5-9. PubMed ID: 15524162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice.
    Rockman HA; Chien KR; Choi DJ; Iaccarino G; Hunter JJ; Ross J; Lefkowitz RJ; Koch WJ
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7000-5. PubMed ID: 9618528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.